Good morning!
Hope this email finds you well. We are currently recruiting candidates for the 
FDA Clinical Pharmacology of Therapeutic Biologics Fellowship at the Office of 
Clinical Pharmacology, Center for Drug Evaluation and Research (CDER), FDA in 
Silver Spring, Maryland. I would greatly appreciate if you can help let all 
NONMEM users on the network know



The Center for Drug Evaluation and Research (CDER) performs an essential public 
health task by making sure that safe and effective drugs are available to 
improve the health of people in the United States. As part of the U.S. Food and 
Drug Administration (FDA), CDER regulates over the counter and prescription 
drugs, including biological therapeutics and generic drugs. This work covers 
more than just medicines.



The participants will gain in-depth knowledge on (1) clinical pharmacology of 
therapeutic proteins by reviewing the PK characteristics of approved products 
(CDER BLAs) and PD properties based on treatment responses measured using 
various biomarkers, (2) regulation and regulatory considerations for biosimilar 
drug development, (3) current practice of study design for clinical 
pharmacology studies in biosimilar programs, (4) information needed to support 
study design, and (5) similarities/dis-similarities in PK and PD among protein 
products.

Qualifications
The qualified candidate should have received a PhD, Pharm D, or MD in one of 
the relevant fields. Degree must have been received within five years of the 
appointment start date.
Computer skills for data manipulation and analysis, experience with 
pharmacokinetic modeling tools is preferred.

Please feel free to reach out to the Fellowship Directors for additional 
questions

Yow-Ming C. Wang, Ph.D.
Associate Director for Biosimilars and Therapeutic Biologics
Therapeutic Biologics Program
Office of Clinical Pharmacology
Office of Translational Sciences
Center for Drug Evaluation and Research
Food and Drug Administration
Phone number: 301-796-0387
Email: yowming.w...@fda.hhs.gov<mailto:yowming.w...@fda.hhs.gov>

Peter ID Lee, PhD
Associate Director, KM
OCP, OTS, CDER, FDA
(301) 796-1561
ider....@fda.hhs.gov<mailto:ider....@fda.hhs.gov>

Best,
Anh

Reply via email to